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Abstract: The risk of a widespread epidemic is a primary public health concern with implications for 
healthcare providers and organizations. Modeling and simulation techniques have been successfully applied 
at the national level to set governmental polices and mitigation strategies through simulation-based 
predictions. Existing research in this field has been non-uniform in its coverage of local systems and region-
specific findings. New collaborations between on the ground providers and modeling groups are required for 
successful simulation-based experimentation of region-specific health systems. These proposed 
collaborations are expected to contribute high-quality sub-population datasets to be used in experiments at the 
national level and allow for the reuse of existing disease models and simulation infrastructure in support of 
regional predictive experimentation. 
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INTRODUCTION 
 
The threat of a global epidemic is an important public health concern. The modeling and simulation community has 
estimated that a pandemic influenza of a size similar to the 1918 Spanish flu outbreak would today result in 150 
million deaths and a $4.4 trillion cost to global economic output (McKibbin 2006). The current state of 
unpreparedness would lead to overwhelmed health infrastructures and disrupted economies. This threat highlights 
the importance of incident response and policy at regional, statewide, national, and global levels. Public health 
planners at multiple levels of governance require methods to set planning strategies and predict the expected impacts 
of policies. Computational epidemiology is a field that studies the health of populations and spread of diseases. 
Modeling and simulation research groups in this community can help local clinics and regional hospitals in setting 
policies during an epidemic.  
  
Public health officials at the federal level rely on simulation-based findings by computational epidemiology 
researchers to set public policies. Disease models, social networks, individual behavior models, public policies, and 
simulation systems are typically used to predict the effects of potential mitigation strategies on the course of a 
disease. Simulation-based experimentation can provide guidelines for public antiviral and vaccine distribution, 
private prophylactic use recommendations, distribution of pharmaceutical kits to selective groups (e.g., health care 
workers and children), individual behavior recommendations (e.g., masks, social distancing, staying home, and 
sequestration of the infected), hospital and healthcare utilization predictions, and community recommendations (e.g., 
local event and public school closures). The analysis of possible policies in these areas currently provides support 
for how to allocate resources, distribute pharmaceutical kits, minimize anticipated costs, and mitigate the spread of 
contagions at the national level.  
 
Similar efforts are needed to produce a body of scientific work to support various public health strategies and 
decisions at the local level. Specifically, best practices are needed to improve local health policies and to 
scientifically predict possible effects of decisions. Collaborations between simulation research groups and local 
healthcare experts are necessary to guide the regional priorities and strategies of public health and clinical systems. 
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PROJECTS AND SOFTWARE TOOLS 
 
The development of epidemiology models and simulation applications requires the expertise of disease modelers, 
computational scientists, medical practitioners, public health officials, statisticians, mathematicians, physicists, and 
entomologists. Disease models, simulation software, and computational infrastructure are produced from extensive 
development efforts that are costly to duplicate between research groups. Designing and executing experimental 
studies using simulation and analysis software requires in depth knowledge of a particular simulation model and 
technical expertise. When done correctly, a simulation infrastructure and experimentation workflow may be used to 
predict the effects, cost, and plausibility of healthcare strategies. Several research groups have epidemiology 
simulation systems in place for experimentation at the level of regional, national, and worldwide scenarios. With 
currently available disease modeling applications, new studies must increasingly be conducted by area experts with 
detailed knowledge of local populations and available resources. To conduct simulation-based experimentation 
leading to real-world policy impacts, collaborations are need between medical experts at health organizations, 
modeling and simulation research groups in academia, and governmental public health agencies, shown in Figure 1. 
 
A large body of existing tools and research exists in computational epidemiology. Disease models and simulation 
applications have been developed with support from organizations such as NIH Models of Infectious Disease Agent 
Study (MIDAS) and the Bill and Melinda Gates Foundation. The public health modeling community has developed 
numerous modeling and decision-making tools using distributed agent-based models and differential equations. 
These models have been used extensively in previous work to set policies for agencies including CDC, NIH, DOD, 
WHO, and the White House.  
 
Figure 1 
Minimal Collaboration Network 
 
 
The diverse nature of vector-borne, contagious, and sexually transmitted disease models require specialized 
simulation applications. Two notable applications are FluTE, a stochastic influenza epidemic simulation model 
(Chao 2010), and OpenMalaria, a publicly available malaria simulation model (Smith 2006). Modeling and 
simulation techniques have been used at the Network Dynamics and Simulation Science Laboratory (NDSSL) to 
study the spread of diseases such as H1N1, H5N1, malaria, smallpox, and pertussis (whopping cough).  
 
Public health researchers and officials have used NDSSL’s existing simulation applications to determine optimal 
vaccine and antiviral distribution strategies, treatment and prophylaxis policies, targeted sub-populations, and dose 
guidelines. These applications have also been used to set policies for school and work closures, isolation of infected 
individuals, social distancing recommendation, public and sporting event closures, pharmaceutical kit selection, 
recommended family interactions, and potential public campaigns (e.g., hand washing, travel guidelines, and mask 
usage). The following are a representative sample of five isolated studies that have included local health case-reports 
and survey data in simulation-based studies of H1N1. 
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In Cauchemez (2009), data were collected from state and local health department case-reports. These reports 
included applicable clinical symptoms and demographic information of infected individuals. This tracking 
information was used in modeling the disease, how it spread, and provided recommendations for families with 
infected members. 
 
Cauchemez (2011) demonstrates how models of local populations can be used in larger scale predictions. This study 
tracked the spread of infections starting in an elementary school in a semirural community in Pennsylvania. The 
school and community social networks were analyzed. The analyses lead to the development of transmission models 
to be used in future studies on the prediction of transmission considering targeted treatments. 
 
Donnelly (2011) consists of analyses covering several local studies of H1N1 cases. The set of local studies includes 
staff, pupils, and family members associated with the New York City school system, a southeastern Pennsylvania 
school system, San Antonio high schools, and Houston school system. The study also included cases from an 
agricultural county on the Mexican border (Imperial County, California) and CDC national case-reports. This 
comprehensive study determined a recommended duration of isolation for infected individuals to reduce the onward 
transmission in future epidemics. These recommendations, along with recommendations for similar issues (e.g., 
school closures), feed into parameter calibrations of ongoing and future simulation studies. 
 
In Chao (2011), simulation models were used to predict the seasonal timing and magnitude of epidemics in Los 
Angeles County. The study aimed to also predict the effects of public campaigns and timing of subsequent waves of 
infection. The results of the study provided a basis for developing appropriate response policies in Los Angeles 
public health departments and clinics. 
 
Matrait (2010) is composed of a traditional comparison of vaccine allocation strategies. The findings of this study 
serve as a guideline for public health planners and services providers. The results detail which groups to treat with 
available resources and when to optimally distribute pharmaceutical kits during an epidemic.  
 
The disease models and simulation infrastructure utilized by NDSSL are based on disaggregated agent-based 
network diffusion processes, now a de facto approach within the simulation community. The set of simulation tools 
produced by NDSSL includes EpiSimdemics public health disease modeling and simulation system (Barrett 2008), 
the EpiFast epidemiology simulation system (Bisset 2009), and the ENteric Immunity SImulator (ENISI) 
immunopathology modeling system (Wendelsdorf 2010). Over a dozen studies using these tools have been 
conducted at the national, statewide, city, and regional levels on behalf of several governmental agencies. These 
studies, at the granularity of individual persons, have included predictions of the spread of influenza through 
military and civilian populations in Alabama (pop. 4,600,000) as well as the spread of smallpox in Portland (Barrett 
2005). Two related studies investigated the interaction between public and private behavior (Barrett 2009), as well 
as the infection and socio-economical impact of mitigation strategies based on individual demographics (Barrett 
2011). The study presented in Barrett (2011) was conducted on the New River Valley (NRV) region in rural 
southwest Virginia (pop. 151,000). ENISI has been used to predict the inflammation and regulatory immune 
pathways considering interactions between individual cells and foreign bacteria in tissues such as the gut. The model 
is used by mucosal immunologists to test hypothesized mechanisms for predicting clinical enteric disease outcomes.  
 
The current set of state-of-the-art modeling and simulation tools are widely missing local clinical information for 
most regions in the U.S. The few areas in the country with real world, high-resolution data on local health systems 
are generally located in the region immediately encompassing a modeling and simulation research group (e.g., 
Virginia Tech and University of Pittsburgh). Increasing the collaboration between research groups, clinicians, and 
area health providers would improve large-scale predictions as well as enable research in setting policies specific to 
a given area. As an example, information on a regional hospital’s expected occupancy, capacity, staffing, patient 
throughput, and medicinal resources would greatly increase the accuracy and validation of simulated predictions that 
lead to the recommendations presented to health officials and providers. 
 
 
OPPORTUNITIES FOR HEALTH CARE DELIVERY 
 
Predictive simulations play an important role in setting public policies and now provide an opportunity to optimize 
practical health care delivery. Hospital modeling, health provider infrastructure modeling, local population 
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modeling, and incident tracking are missing components in current public health research efforts. Systematic 
collaborations are currently needed between modelers and hospital IT staff to produce a comprehensive set of 
hospital and health provider models. These models would ideally be structured into a framework along with disease 
modeling and simulation systems to assist providers in disaster preparation. Specifically, the composition of disease 
and health provider models provide predictions on staff overload, resource shortages, capacity requirements, and 
patient routing during a disaster scenario. In some cases, these simulations also may be used to guide clinicians and 
practitioners in delivery activities based on the predicted high-impact procedures. Simulations also assist in non-
medicinal planning by guiding recommendations that reduce the stress on health systems such as private behavior 
modifications, preventative measures, insecticide usage, and bed-netting usage (in tropical locations). Higher-
resolution information on individual regions, when agglomerated at the national level, may be used to provide 
pertinent local public health recommendations while improving the accuracy of national studies. Littig (2007) 
provides a case study of the impact modeling can have on producing accurate predictions and advanced knowledge 
forecasts for future hospital occupancy and service requirements. This study used historical data from an area 
hospital to model inpatient census, occupancy by unit and shift, resource use and fluctuation, staffing requirements, 
bed management, ambulance diversions, and patient care quality. Including this information in disaster simulations 
provides predictions and suggestions on current areas of a health infrastructure that need improvement. The 
computing infrastructure provided by modeling and simulation research groups also eases communication and 
dissemination of findings to rural and poor regions and provides a central medium of reviewing previous studies; see 
SimDL, a simulation-supporting digital library (Leidig 2011). SimDL has been developed for the purpose of 
managing the underlying datasets, disease models, population models, experimental designs, study results, analyses, 
and publications for research produced through simulation systems. This digital library services as a portal for 
collaborations between healthcare providers who are contributing information on local health infrastructure and 
modelers, software developers, analysts, and public health officials. SimDL also serves as an access point for 
hospital managers, providers, and IT staff to discover recent predictive studies and recommended disaster planning 
policies. Previous experiences in malaria research have showcased the mutual benefits of collaborations between 
modeling research groups and area health providers; see Swiss Tropical Institute (Switzerland) and Ifakara Health 
Institute (Tanzania). While there are current epidemic surveillance and mitigation systems in place by state and 
national authorities, there is disappointingly little collaboration between public health researchers and health 
providers in setting epidemic-related policies.  
 
 
ROLE OF THE HEALTH CARE PROVIDER AND IT PROFESSIONAL 
 
The potential of intelligent disease modeling and mitigation will only be realized through the emergence of 
collaborations between health providers, provider IT staff, clinicians, modeling and simulation groups, and public 
health officials at all levels of government. Efforts by health care and IT professionals are needed to provide local 
datasets that will improve national and local health care modeling. By contributing data on local health systems, the 
accuracy and quality of health model are improved at the national level. In addition, this data can be used in micro-
simulations that use existing high-quality simulation applications. By restricting the scope of the simulations to use 
only locally provided datasets, local health system planners receive access to previously unavailable simulation-
based predictions and analysis of their systems. IT staff will need to play a significant role in providing anonymous 
and summarized patient data to modelers while adhering to internal privacy requirements. In the reverse direction, 
IT professionals will need to review predictions, made by the modeling community, of hospital utilization during a 
disaster in order for members of management to set internal policies. IT staff also play a role in the early 
identification and reporting of emerging diseases and epidemics through data organization and mining practices. The 
reporting of detailed inpatient modeling, similar to Littig (2007), in addition to published surveillance data by NIH 
and CDC, are necessary for the modeling community to conduct accurate simulation-based experimentation. 
Improving the quality and resolution of datasets used by existing modeling tools directly benefits health providers. 
The products of modeling tools are currently being used to set national policies, as previously discussed, and will 
provide a new class of simulation-supported findings in how health care providers should optimally utilize resources 
and recommend behavior modifications to patients (e.g., out-patient sequestering). 
 
NDSSL’s existing modeling and simulation software applications have been developed to execute on large-scale 
computing resources. These applications are capable of handling multiple disease models and underlying population 
data. New disease models and healthcare system models, when formatted correctly, may be directly utilized without 
any modifications to the simulation software. SimDL provides a point for storing and managing models of 
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healthcare systems and the population each system supports. Each modeling and simulation group has developed 
custom formats for describing healthcare and population models. Unfortunately, model formats are currently 
incompatible between modeling research groups, although there have been some efforts to standardize and translate 
between formats. Direct collaborations are needed between individual healthcare providers and modeling groups to 
produce a new class healthcare models. NDSSL has previously produced population models based on census data 
and activity modeling. Individuals in these synthetic populations are attached with demographic information (e.g., 
age, income level, address, family size, and daily schedule). To produce a model of a healthcare provider, modelers 
and healthcare providing organizations must provide information related to descriptive capabilities (e.g., beds, 
staffing, and resources), usage history (e.g., baseline unit utilization and throughput), and the population served 
(selected as a subset of the existing U.S. population model). 
 
Previous collaborations between several state health departments and the modeling community have successfully 
produced tools (e.g., simulation visualizations) that rely on hospital data and population information to inform 
disaster planning decision-making at the state level. In domains supported by computing efforts, data collected for 
one purpose may often be reused later in different contexts. The prediction and optimization uses of inpatient data 
along with hospital and provider capability modeling may have beneficial, currently unforeseen public health uses 
(e.g., tracking infections within a hospital). As a caveat learned from decisions at the national level, analysts at 
health providing organizations would do well to remember that setting antiviral and vaccine purchasing and 
distribution policies based on simulation studies must consider healthcare imperfections such as waste, misuse, and 
misdiagnosis. 
 
 
CONCLUSIONS 
 
Computational epidemiology modeling and simulation research has been extensively used to set national public 
health policies. Data and models covering the health systems, capabilities, and anticipated needs of local regions are 
generally unavailable. Higher resolution simulation-based experiments will require the widespread availability of 
regional healthcare system datasets. Several existing studies have shown the benefits these datasets have on 
predictions for multiple infrastructure planning and policy issues. Previous high-quality, high-performance 
simulation systems have required large amounts of federal and private funding. Development of state or regionally 
specific simulation infrastructures is unsustainable and impractical. Existing simulation tools may be made available 
to local planners and health care providers, given mutual collaborations in the experimentation process. To get 
involved in disaster planning and resource optimization processes, healthcare providers will need to contribute 
models of local health systems. These regional models of health systems and usage statistics may be plugged into 
existing public health simulation systems. The authors call for future systematic collaborations between health 
providers and leading simulation groups with previous experience in modeling health systems the national level.  
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